Mood disorders and obesity: understanding inflammation as a pathophysiological nexus.
about
Mood disorders: A potential link between ghrelin and leptin on human body?Role of microglia in CNS inflammationConsiderations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 DiabetesAdvancing biomarker research: utilizing 'Big Data' approaches for the characterization and prevention of bipolar disorder.Diabetes mellitus and disturbances in brain connectivity: a bidirectional relationship?Systems biology integration of proteomic data in rodent models of depression reveals involvement of the immune response and glutamatergic signaling.Risk of obstructive sleep apnea and excessive daytime sleepiness in hospitalized psychiatric patients.Depression and alexithymia on weight perception in patients with metabolic syndrome and type 2 diabetes.Inflammation: opportunities for treatment stratification among individuals diagnosed with mood disorders.What is the Importance of Body Composition in Obesity-related Depression?Obesity-Related Hormones in Low-Income Preschool-Age Children: Implications for School Readiness.Moving towards a population health approach to the primary prevention of common mental disorders.Eating behaviors, mental health, and food intake are associated with obesity in older congregate meal participantsPotential Antidepressant Role of Neurotransmitter CART: Implications for Mental DisordersHypothalamic stimulation enhances hippocampal BDNF plasticity in proportion to metabolic rate.Quantifying the effect of body mass index, age, and depression severity on 24-h activity patterns in persons with a lifetime history of affective disorders.Methylphenidate prevents high-fat diet (HFD)-induced learning/memory impairment in juvenile miceAcute psychological stress results in the rapid development of insulin resistanceDietary restriction reverses obesity-induced anhedoniaBeyond pharmacotherapy: understanding the links between obesity and chronic mental illness.Olanzapine-induced weight gain in patients with bipolar I disorder: a meta-analysis.Obesity and mental illness: implications for cognitive functioning.Obesity and bipolar disorder: synergistic neurotoxic effects?Altered behavior of adult obese rats by monosodium l-glutamate neonatal treatment is related to hypercorticosteronemia and activation of hypothalamic ERK1 and ERK2.Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites.Are medical comorbid conditions of bipolar disorder due to immune dysfunction?An Overview of Links Between Obesity and Mental Health.Obesity and sex interact in the regulation of Alzheimer's disease.Depression, obesity, and metabolic syndrome: prevalence and risks of comorbidity in a population-based representative sample of Mexican Americans.Body Mass Index and Depressive Symptoms: Testing for Adverse and Protective Associations in Two Twin Cohort Studies.Gender-Specific Relationship between Obesity and Major Depression.Gender-specific alteration of energy balance and circadian locomotor activity in the Crtc1 knockout mouse model of depression.Does obesity along with major depression or anxiety lead to higher use of health care and costs? A 6-year follow-up study.Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications.Body mass index associates with white matter microstructure in bipolar depression.Extracellular matrix proteins matrix metallopeptidase 9 (MMP9) and soluble intercellular adhesion molecule 1 (sICAM-1) and correlations with clinical staging in euthymic bipolar disorder.Executive functioning in obstructive sleep apnea syndrome patients without comorbidities: focus on the fractionation of executive functions.Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls.Influence of body mass index on psychological and functional outcomes in patients with multiple sclerosis: a cross-sectional study.Body mass index and depressive symptoms: instrumental-variables regression with genetic risk score.
P2860
Q26862798-336488BF-F655-4E66-8A06-9163447F86B2Q27023760-6862F336-6EEB-4631-A693-AE37A8648F1EQ28073309-58BF62A4-07BD-4D63-8E91-B9D04785EF05Q30713152-D481010A-A6D9-405E-A50D-CC44B520B685Q30833828-0D527A13-43F3-4CA1-9263-4F25125B031AQ31128463-5090984E-D627-464F-9ED1-81DDA5E5B6D8Q33631311-D918D079-F7EB-4A3B-81AB-4753531F42DAQ33676990-0CF1A200-2086-4634-92F5-AFB37FA460C1Q33721019-71CCCE8C-8EBA-47B7-A964-2143CF3FB92AQ33794321-B6B9F5AA-E594-444D-B873-9B4D285BCF85Q34290086-2D341A1B-A6C6-4108-80CB-5DF171011E4EQ34491862-52F77D66-74EE-40EA-918F-7D6FA7E63C31Q35095388-5FA697E5-F810-4263-B1FD-2F0C208F8421Q35110380-AE2BA581-DC62-473D-9568-1C5643A4A79EQ36059073-4D18AECB-2759-4419-90CA-A8245218FF6FQ36128727-7805C485-860B-4D1F-A808-A3D440B608F8Q36859755-E1424997-B73D-4616-96ED-324A95556F58Q37244949-4BBD055F-E835-4AF6-AD7F-90D214F94E25Q37719351-3E32AA8C-B1F7-4C8A-9000-FE3B2E4EA59DQ37980570-1FCCAB9A-DF69-4490-AD0A-F66769CBC9C2Q37997775-350F64FB-611B-48E6-8EB7-5ACDBF866A3BQ38120446-0FDA2ABB-502A-4999-B8C4-21D6D7F10191Q38160202-5C6ADD35-F137-4608-B83C-0C50007769C3Q38301039-8A5D5879-FC0C-41AE-8C74-399BDE5434D1Q38332353-43A3947B-D892-4147-89C9-2EBDA1CC8B80Q38378743-9DA7B717-6C90-441E-AD93-8ADB03B3EF47Q38655964-07D097FB-9224-42F9-B3EB-E25FB2A9F1C6Q38680759-B946DD78-67B3-45BD-B4AC-E09C4780E219Q40362288-C2FAE6DE-8094-4757-846E-C4A6666C904AQ40812473-902984EB-85A1-4F1D-B6F0-5ECCB67F8E29Q47128542-D7441504-13A1-42C5-848D-2CF3C05CFC94Q47271304-AB537F38-5764-4D05-A669-A6E43E7A45FEQ47600362-AE425797-6065-420F-ABFF-40FB2F0E602DQ47667767-08BAA4F1-6528-4AE7-85EB-5F0C1D1AA54CQ47913705-CB7522F4-BD6B-43B3-B171-6C4117EF971AQ48060018-64B6A51E-AE88-43CD-B413-02974EF657EEQ48139897-56D88A66-F020-4B80-9ED2-A4CB0086C2F9Q48204136-E7B6475B-0A64-4C62-B5F0-283585D21148Q48212346-C804DAD8-8A2C-4090-832D-5752E343A8A4Q48385237-E12E2CF9-71D2-4E5F-9B9A-F75A6C97C22B
P2860
Mood disorders and obesity: understanding inflammation as a pathophysiological nexus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mood disorders and obesity: understanding inflammation as a pathophysiological nexus.
@en
Mood disorders and obesity: understanding inflammation as a pathophysiological nexus.
@nl
type
label
Mood disorders and obesity: understanding inflammation as a pathophysiological nexus.
@en
Mood disorders and obesity: understanding inflammation as a pathophysiological nexus.
@nl
prefLabel
Mood disorders and obesity: understanding inflammation as a pathophysiological nexus.
@en
Mood disorders and obesity: understanding inflammation as a pathophysiological nexus.
@nl
P2093
P2860
P921
P1476
Mood disorders and obesity: understanding inflammation as a pathophysiological nexus.
@en
P2093
Christina Y Yim
Hanna O Woldeyohannes
Roger S McIntyre
Samantha S Liauw
Sidney H Kennedy
P2860
P2888
P304
P356
10.1007/S12017-010-8140-8
P577
2010-12-17T00:00:00Z